Gene · 574455
Papers2,200
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,200
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Domestic Animal Models of Central Nervous System Tumors: Focus on Meningiomas. | Life (Basel) | 2023 | 38137885 | PubTator, text mining | PubMed |
| MicroRNA193a: An Emerging Mediator of Glomerular Diseases. | Biomolecules | 2023 | 38136614 | PubTator, text mining | PubMed |
| Integrated Analysis of lncRNA-miRNA-mRNA Regulatory Network in Rapamycin-Induced Cardioprotection against Ischemia/Reperfusion Injury in Diabetic Rabbits. | Cells | 2023 | 38132140 | PubTator, text mining | PubMed |
| Age-related changes in human bone marrow mesenchymal stromal cells: morphology, gene expression profile, immunomodulatory activity and miRNA expression. | Front Immunol | 2023 | 38130717 | PubTator, text mining | PubMed |
| miRNA-137-5p improves spatial memory and cognition in Alzheimer's mice by targeting ubiquitin-specific peptidase 30. | Animal Model Exp Med | 2023 | 38111333 | PubTator, text mining | PubMed |
| The role of tumor-associated macrophages in hepatocellular carcinoma progression: A narrative review. | Cancer Med | 2023 | 38098217 | PubTator, text mining | PubMed |
| The Research Progress in Transforming Growth Factor-β2. | Cells | 2023 | 38067167 | PubTator, text mining | PubMed |
| The physiological functions and therapeutic potential of exosomes during the development and treatment of polycystic ovary syndrome. | Front Physiol | 2023 | 38028777 | PubTator, text mining | PubMed |
| MYLK and CALD1 as molecular targets in bladder cancer. | Medicine (Baltimore) | 2023 | 38013282 | PubTator, text mining | PubMed |
| Knockdown of Simulated-Solar-Radiation-Sensitive miR-205-5p Does Not Induce Progression of Cutaneous Squamous Cell Carcinoma In Vitro. | Int J Mol Sci | 2023 | 38003618 | PubTator, text mining | PubMed |
| Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer's Disease. | Int J Mol Sci | 2023 | 38003448 | PubTator, text mining | PubMed |
| Non-Coding RNAs in Human Cancer and Other Diseases: Overview of the Diagnostic Potential. | Int J Mol Sci | 2023 | 38003403 | PubTator, text mining | PubMed |
| Expression Profiling of Adipogenic and Anti-Adipogenic MicroRNA Sequences following Methylmercury Exposure in Caenorhabditis elegans. | Toxics | 2023 | 37999587 | PubTator, text mining | PubMed |
| ALOX5AP is a new prognostic indicator in acute myeloid leukemia. | Discov Oncol | 2023 | 37994961 | PubTator, text mining | PubMed |
| Transcriptome sequencing and microRNA-mRNA regulatory network construction in the lens from a Na2SeO3-induced Sprague Dawley rat cataract model. | BMC Ophthalmol | 2023 | 37974089 | PubTator, text mining | PubMed |
| Novel mediator in anaphylaxis: decreased levels of miR-375-3p in serum and within extracellular vesicles of patients. | Front Immunol | 2023 | 37965316 | PubTator, text mining | PubMed |
| Identification ferroptosis-related hub genes and diagnostic model in Alzheimer's disease. | Front Mol Neurosci | 2023 | 37965040 | PubTator, text mining | PubMed |
| Stem cells and exosomes: as biological agents in the diagnosis and treatment of polycystic ovary syndrome (PCOS). | Front Endocrinol (Lausanne) | 2023 | 37964963 | PubTator, text mining | PubMed |
| Change in expressional level and clinicopathological significance of miR-193b-3p in non-small cell lung cancer. | Medicine (Baltimore) | 2023 | 37960820 | PubTator, text mining | PubMed |
| MicroRNA Landscape in Endometrial Carcinomas in an Asian population: Unraveling Subtype-Specific Signatures. | Cancers (Basel) | 2023 | 37958433 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/574455/papers?page=5